Cover Image
Issue Information
Hepatitis C virus genotype 4
Secondary prophylaxis of hepatocellular carcinoma
Community‐based real‐world treatment outcomes of sofosbuvir/ledipasvir in Asians with chronic hepatitis C virus genotype 6 in the United States
Real‐world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C
Virology analyses of HCV genotype 4 isolates from patients treated with simeprevir and peginterferon/ribavirin in the Phase III RESTORE study
Analysis of resistance‐associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents
Phylogenetic analysis of full‐length, early infection, hepatitis C virus genomes among people with intravenous drug use
Factors associated with poor adherence to antiviral treatment for hepatitis B
Patients with HBV‐related acute‐on‐chronic liver failure have increased concentrations of extracellular histones aggravating cellular damage and systemic inflammation
No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg− patients with chronic hepatitis B after 8 years of treatment
Time course of hepatitis E‐specific antibodies in adults
Diagnostic accuracy of des‐gamma‐carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse® G600 analyzer
Hepatitis C in nonobese nondiabetic patients